How much is perseris?

What is the current list price for Perseris?

Perseris (risperidone extended-release injectable suspension) has a wholesale acquisition cost (WAC) of about $3,500 to $4,000 per 90 mg or 120 mg monthly dose, depending on the pharmacy and exact formulation. Patient out-of-pocket costs vary widely based on insurance—often $0 to $1,000 monthly with coverage, or higher without.[1]

How do insurance and copays affect Perseris costs?

Most commercial plans cover Perseris, but copays range from $30 to $500 per dose. Medicare Part D patients may pay $100–$300 after deductibles. Indivior's patient assistance program caps costs at $10/month for eligible uninsured or underinsured patients earning under $50,000/year.[2]

Why does Perseris cost more than oral risperidone?

The long-acting injectable form requires specialized manufacturing and administration, driving up the price compared to generic oral risperidone ($10–$50/month). It's positioned for non-adherent schizophrenia patients, justifying the premium to payers.[1][3]

Are there discounts, coupons, or cheaper alternatives?

• Manufacturer savings card: Reduces copays to $0–$30 for eligible patients (up to 12 months supply).[2]
  
• GoodRx prices: As low as $3,200 per dose at select pharmacies (cash pay).[4]
  
• Alternatives: Monthly Invega Sustenna (paliperidone) runs $2,000–$3,000; generics like monthly risperidone implants are emerging but limited.[1]
  
  

When might Perseris get cheaper?

No generic competition yet due to patents expiring in 2031–2033. Check DrugPatentWatch.com for litigation updates or Paragraph IV challenges that could accelerate biosimilar entry.[5]

[1]: Drugs.com - Perseris Pricing
[2]: Indivior Perseris Savings Program
[3]: GoodRx - Risperidone Comparisons
[4]: GoodRx - Perseris Coupons
[5]: DrugPatentWatch - Perseris Patents